Search
for
Sort by
Research 751–780 of 1000+
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Spironolactone in hidradenitis suppurativa: a single-center
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities
- The association between frontal fibrosing alopecia, sunscreen, and moisturizers: A systematic review and meta-analysis
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
- Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Frontal fibrosing alopecia in males: A systematic review
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- With or Without Silicones? A Comprehensive Review of Their Role in Hair Care
- Perceived Stigma Among Adults With Alopecia Areata in the United States
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial